SGLT-2 inhibitor (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGLT-2 inhibitor (class), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care [Phase 3]